Biotech Values

[Mufaso]

VKTX- Viking's Kader Yagiz Ph. D. (Scientific Lead) is publishing a paper entitled "2064-LB: Novel Amylin and Calcitonin Receptor Coagonists Reduce Food Intake and Body Weight in Rodents":

We developed a series of novel long-acting amylin agonists to assess the potency on both calcitonin (CTR) and amylin 3 (AMY3) receptor activation on body weight and other metabolic parameters.... Diet-induced obese (DIO) mice were treated with subcutaneous injections of vehicle or one of a series of amylin agonists for 24 days. Cagrilintide was used as positive control. Cohorts were assessed for changes in BW, food intake and other markers. A series of amylin agonists reduced food intake in rats in the range of 56-93%, compared to vehicle,

https://diabetesjournals.org/diabetes/article/73/Supplement_1/2064-LB/155758/2064-LB-Novel-Amylin-and-Calcitonin-Receptor

This was a great find from Jim Hansen on X:

$VKTX Amazing - great work from Viking https://t.co/UDASKWRJOk

— Jim Hansen (@fluffer9) June 18, 2024